Autolus Therapeutics plc Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q4 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Autolus Therapeutics plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2017 to Q1 2024.
  • Autolus Therapeutics plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $561M.
  • Autolus Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$883K, a 100% decline from 2022.
  • Autolus Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $224M, a 21.3% decline from 2021.
  • Autolus Therapeutics plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $284M, a 282% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $561M +$562M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q1 2023 -$691K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q1 2021 $123M +$49M +66% Jan 1, 2021 Mar 31, 2021 6-K 2021-05-06
Q1 2020 $74.3M +$74.3M Jan 1, 2020 Mar 31, 2020 6-K 2021-05-06
Q1 2019 $4K* Jan 1, 2019 Mar 31, 2019 6-K 2020-05-07
Q4 2018 $0 -$433K -100% Oct 1, 2018 Dec 31, 2018 20-F 2021-03-04
Q4 2017 $433K Oct 1, 2017 Dec 31, 2017 20-F 2019-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.